550
Views
37
CrossRef citations to date
0
Altmetric
Treatment and Outcomes

Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma

, &
Pages 994-1000 | Published online: 08 Nov 2010

References

  • Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114:1288–1293.
  • Bender B, Wamboldt FS, O'Connor SL, Rand C, Szefler S, Milgrom H, Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85:416–421.
  • McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol 2003; 28:323–333.
  • Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002; 110:58–64.
  • Haughney J, Barnes G, Partridge M, Cleland J. The Living & Breathing Study: a study of patients' views of asthma and its treatment. Prim Care Respir J 2004; 13:28–35.
  • Jones BL, Kelly KJ. The adolescent with asthma: fostering adherence to optimize therapy. Clin Pharmacol Ther 2008; 84:749–753.
  • Bruzzese JM, Bonner S, Vincent EJ, Sheares BJ, Mellins RB, Levison MJ, Asthma education: the adolescent experience. Patient Educ Couns 2004; 55:396–406.
  • Dinwiddie R, Muller WG. Adolescent treatment compliance in asthma. J R Soc Med 2002; 95:68–71.
  • Calmes D, Leake BD, Carlisle DM. Adverse asthma outcomes among children hospitalized with asthma in California. Pediatrics 1998; 101:845–850.
  • Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest 2005; 128: 1968–1973.
  • Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB. Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med 1998; 157:1173–1180.
  • National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report. 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed January 19, 2010.
  • Asmanex®Twisthaler® (mometasone furoate). Full Prescribing Information, Merck & Co., Whitehouse Station, NJ, 2008.
  • Flovent® Diskus® (fluticasone propionate inhalation powder). Full Prescribing Information, GlaxoSmithKline, Research Triangle Park, NC, 2005.
  • Flovent® HFA (fluticasone propionate inhalation aerosol). Full Prescribing Information, GlaxoSmithKline, Research Triangle Park, NC, 2007.
  • Friedman HS, Yawn BP. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Curr Med Res Opin 2007; 23:427–434.
  • Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10:3–12.
  • Black P. Greedy algorithm. In: Black PE, ed. Dictionary of Algorithms and Data Structures [online], U.S. National Institute of Standards and Technology.Available at: http://www.itl.nist.gov/div897/sqg/dads/HTML/greedyalgo.html. Accessed 5 July 2010.
  • Navaratnam P, Urdaneta E, Friedman HS. A multivariate outcomes analysis of mometasone furoate versus fluticasone propionate outcomes in mild persistent asthmatics with prior asthma medication use. J Allergy Clin Immunol 2009; 123:S42.
  • Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57–62.
  • Senthilselvan A, Lawson JA, Rennie DC, Dosman JA. Regular use of corticosteroids and low use of short-acting beta2-agonists can reduce asthma hospitalization. Chest 2005; 127:1242–1251.
  • Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J 2001; 17:233–240.
  • Food and Drug Administration. Use of ozone-depleting substances; removal of essential-use designations; final rule. Fed Regist 2005; 70:17168–17192.
  • Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23:1296–1310.
  • Molimard M, Le Gros V. Impact of patient-related factors on asthma control. J Asthma 2008; 45:109–113.
  • Stern L, Berman J, Lumry W, Katz L, Wang L, Rosenblatt L, Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol 2006; 97:402–408.
  • Gillissen A. Patients' adherence in asthma. J Physiol Pharmacol 2007; 58:205–222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.